vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Wendy's Co (WEN). Click either name above to swap in a different company.
Wendy's Co is the larger business by last-quarter revenue ($543.0M vs $493.8M, roughly 1.1× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 4.9%, a 1.9% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -5.5%). Over the past eight quarters, Wendy's Co's revenue compounded faster (0.8% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
The Wendy's Company is an American fast food corporation and the holding company for Wendy's and First Kitchen. Originally founded as the Deisel-Wemmer Company, it is headquartered in Dublin, Ohio. The company's principal subsidiary, Wendy's International, is the franchisor of Wendy's restaurants.
MD vs WEN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $543.0M |
| Net Profit | $33.7M | $26.5M |
| Gross Margin | — | 62.7% |
| Operating Margin | 9.9% | 11.8% |
| Net Margin | 6.8% | 4.9% |
| Revenue YoY | -1.7% | -5.5% |
| Net Profit YoY | 10.5% | -44.2% |
| EPS (diluted) | $0.40 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $543.0M | ||
| Q3 25 | $492.9M | $549.5M | ||
| Q2 25 | $468.8M | $560.9M | ||
| Q1 25 | $458.4M | $523.5M | ||
| Q4 24 | $502.4M | $574.3M | ||
| Q3 24 | $511.2M | $566.7M | ||
| Q2 24 | $504.3M | $570.7M | ||
| Q1 24 | $495.1M | $534.8M |
| Q4 25 | $33.7M | $26.5M | ||
| Q3 25 | $71.7M | $44.3M | ||
| Q2 25 | $39.3M | $55.1M | ||
| Q1 25 | $20.7M | $39.2M | ||
| Q4 24 | $30.5M | $47.5M | ||
| Q3 24 | $19.4M | $50.2M | ||
| Q2 24 | $-153.0M | $54.6M | ||
| Q1 24 | $4.0M | $42.0M |
| Q4 25 | — | 62.7% | ||
| Q3 25 | — | 62.8% | ||
| Q2 25 | — | 65.0% | ||
| Q1 25 | — | 64.1% | ||
| Q4 24 | — | 65.9% | ||
| Q3 24 | — | 65.5% | ||
| Q2 24 | — | 65.0% | ||
| Q1 24 | — | 64.1% |
| Q4 25 | 9.9% | 11.8% | ||
| Q3 25 | 13.8% | 16.8% | ||
| Q2 25 | 12.8% | 18.6% | ||
| Q1 25 | 7.0% | 15.9% | ||
| Q4 24 | 7.8% | 16.7% | ||
| Q3 24 | 6.6% | 16.7% | ||
| Q2 24 | -31.3% | 17.4% | ||
| Q1 24 | 3.2% | 15.2% |
| Q4 25 | 6.8% | 4.9% | ||
| Q3 25 | 14.5% | 8.1% | ||
| Q2 25 | 8.4% | 9.8% | ||
| Q1 25 | 4.5% | 7.5% | ||
| Q4 24 | 6.1% | 8.3% | ||
| Q3 24 | 3.8% | 8.9% | ||
| Q2 24 | -30.3% | 9.6% | ||
| Q1 24 | 0.8% | 7.9% |
| Q4 25 | $0.40 | $0.14 | ||
| Q3 25 | $0.84 | $0.23 | ||
| Q2 25 | $0.46 | $0.29 | ||
| Q1 25 | $0.24 | $0.19 | ||
| Q4 24 | $0.37 | $0.23 | ||
| Q3 24 | $0.23 | $0.25 | ||
| Q2 24 | $-1.84 | $0.27 | ||
| Q1 24 | $0.05 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $300.8M |
| Total DebtLower is stronger | $570.5M | $2.8B |
| Stockholders' EquityBook value | $865.9M | $117.4M |
| Total Assets | $2.2B | $5.0B |
| Debt / EquityLower = less leverage | 0.66× | 23.51× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $300.8M | ||
| Q3 25 | $340.1M | $291.4M | ||
| Q2 25 | $224.7M | $281.2M | ||
| Q1 25 | $99.0M | $335.3M | ||
| Q4 24 | $229.9M | $450.5M | ||
| Q3 24 | $103.8M | $482.2M | ||
| Q2 24 | $19.4M | $465.5M | ||
| Q1 24 | $8.0M | $498.3M |
| Q4 25 | $570.5M | $2.8B | ||
| Q3 25 | $577.2M | $2.7B | ||
| Q2 25 | $583.9M | $2.7B | ||
| Q1 25 | $590.5M | $2.7B | ||
| Q4 24 | $597.1M | $2.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $117.4M | ||
| Q3 25 | $890.7M | $109.2M | ||
| Q2 25 | $833.8M | $112.9M | ||
| Q1 25 | $789.2M | $130.2M | ||
| Q4 24 | $764.9M | $259.4M | ||
| Q3 24 | $732.5M | $259.9M | ||
| Q2 24 | $706.5M | $273.8M | ||
| Q1 24 | $856.2M | $293.7M |
| Q4 25 | $2.2B | $5.0B | ||
| Q3 25 | $2.2B | $5.0B | ||
| Q2 25 | $2.1B | $4.9B | ||
| Q1 25 | $2.0B | $4.9B | ||
| Q4 24 | $2.2B | $5.0B | ||
| Q3 24 | $2.1B | $5.1B | ||
| Q2 24 | $2.0B | $5.1B | ||
| Q1 24 | $2.2B | $5.2B |
| Q4 25 | 0.66× | 23.51× | ||
| Q3 25 | 0.65× | 24.95× | ||
| Q2 25 | 0.70× | 24.18× | ||
| Q1 25 | 0.75× | 21.00× | ||
| Q4 24 | 0.78× | 10.57× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $69.3M |
| Free Cash FlowOCF − Capex | — | $31.4M |
| FCF MarginFCF / Revenue | — | 5.8% |
| Capex IntensityCapex / Revenue | — | 7.0% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $242.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $69.3M | ||
| Q3 25 | $137.3M | $129.3M | ||
| Q2 25 | $137.2M | $60.6M | ||
| Q1 25 | $-117.5M | $85.4M | ||
| Q4 24 | $133.0M | $68.6M | ||
| Q3 24 | $91.8M | $141.2M | ||
| Q2 24 | $107.0M | $45.5M | ||
| Q1 24 | $-125.2M | $100.0M |
| Q4 25 | — | $31.4M | ||
| Q3 25 | — | $104.3M | ||
| Q2 25 | — | $39.2M | ||
| Q1 25 | — | $67.7M | ||
| Q4 24 | — | $26.6M | ||
| Q3 24 | — | $123.3M | ||
| Q2 24 | — | $28.4M | ||
| Q1 24 | — | $82.6M |
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 7.0% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 5.0% | ||
| Q1 24 | — | 15.5% |
| Q4 25 | — | 7.0% | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 3.39× | 2.62× | ||
| Q3 25 | 1.91× | 2.92× | ||
| Q2 25 | 3.49× | 1.10× | ||
| Q1 25 | -5.66× | 2.18× | ||
| Q4 24 | 4.36× | 1.44× | ||
| Q3 24 | 4.72× | 2.81× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | -31.03× | 2.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WEN
| Franchise Royalty Revenueand Fees | $149.3M | 27% |
| Royalty | $103.6M | 19% |
| Advertising | $103.3M | 19% |
| Global Real Estate Development | $60.5M | 11% |
| Real Estate | $59.5M | 11% |
| Wendys International | $39.5M | 7% |
| Franchise | $21.5M | 4% |
